Investors & Media

 
Select:
Nov 15, 2019
International Stem Cell Corporation Announces Financial Results for the Three and Nine-Months ended September 30, 2019

May 17, 2019
International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2019

May 08, 2019
International Stem Cell Corporation is Valued at $43 Million Market Value by Edison Investment Research

Apr 29, 2019
International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical Trial

Apr 15, 2019
International Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End Results

Mar 04, 2019
International Stem Cell Corporation Commences Trading on the OTCQX Best Market

Feb 13, 2019
International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury

Jan 15, 2019
International Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging Business

Nov 15, 2018
International Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018

Nov 05, 2018
International Stem Cell Corporation Announces Positive Top-Line Preliminary Results from Parkinson's Disease Clinical Trial

   1    2   3   4   5   6 
 <<   <   >   >>